Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Ensem Therapeutics
Atavistik Bio, Inc
QuantumLeap Healthcare Collaborative
Eisai Inc.
Institut du Cancer de Montpellier - Val d'Aurelle
NeoImmuneTech
Alterome Therapeutics, Inc.
Duke University
Baptist Health South Florida
George Washington University
Psyence Australia Pty Ltd
Eli Lilly and Company
ViroMissile, Inc.
Replimune Inc.
Institut Curie
Duke University
University of Florida
University of Missouri-Columbia
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
AstraZeneca
University of Salamanca
TNC Nutrición Terapéutica S.L.
Angiex, Inc.
Case Comprehensive Cancer Center
Stemline Therapeutics, Inc.
UNC Lineberger Comprehensive Cancer Center
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Cancer Research Antwerp
Unity Health Toronto
Iambic Therapeutics, Inc
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Case Comprehensive Cancer Center
Centre Hospitalier de Valenciennes
Vanderbilt-Ingram Cancer Center
DualityBio Inc.
Case Comprehensive Cancer Center
AstraZeneca
Colorado State University
HealthPartners Institute
Hospices Civils de Lyon
M.D. Anderson Cancer Center
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Tolmar Inc.
University of Alberta
King's College London
Eli Lilly and Company